Tarsus Pharmaceuticals reports Q3 2026 financial results
Tarsus Pharmaceuticals, Inc. shares its Q3 2026 financial results, detailing progress and developments in the biological products sector.
AES Corp Reports Q3 Results, Highlights Growth Strategies
AES Corp's Q3 2026 results show growth and strategic initiatives in the cogeneration services sector, impacting the energy industry landscape.
Mercury General announces third-quarter results and dividend
Mercury General Corporation reports strong third-quarter results with increased net premiums and declares a quarterly dividend.
FS Credit Real Estate Income Trust Enters New Financial Agreement
FS Credit Real Estate Income Trust, Inc. announces a new financial agreement that could reshape its obligations and impact the real estate investment trust sector.
DiamondRock Hospitality Reports Strong Q3 2026 Results
DiamondRock Hospitality Co announces impressive Q3 2026 results, raising full-year guidance amid a recovering lodging sector.
Ultragenyx completes $210 million sale of PRV voucher
Ultragenyx Pharmaceutical Inc. completes $210 million sale of its Rare Pediatric Disease Priority Review Voucher, impacting its financial strategy.
Flux Power Holdings reports Q1 results, shares estimates
Flux Power Holdings, Inc. announces its Q1 financial results and forward-looking estimates for the fiscal year ending September 30, 2026.
InnovAge reports strong Q1 results, highlights growth in services
InnovAge Holding Corp. announces strong financial results for Q1 2026, showcasing growth in healthcare services for seniors.
Cricut Reports Strong Q3 Results with 11% Revenue Growth
Cricut, Inc. announces Q3 2026 results, showcasing 11% revenue growth and a 36% increase in net income, highlighting strong performance in the machinery sector.
Bunge Global amends securitization program, extends deadline
Bunge Global SA extends its trade receivables securitization program to December 2027, reflecting strategic financial flexibility in the fats and oils sector.
Coupang Reports Q3 2026 Results with Mixed Financials
Coupang, Inc. announces Q3 2026 results, showing a 7% revenue increase but significant operating losses, highlighting challenges in the retail sector.
Ouster Reports Record Revenue, 15th Straight Quarter of Growth
Ouster, Inc. announces strong Q3 2026 results with record revenue and sensor shipments, marking its 15th consecutive quarter of growth.
Zevra Therapeutics Reports Strong Q3 2026 Financial Results
Zevra Therapeutics announces strong Q3 2026 results, driven by MIPLYFFA, reflecting growth in the pharmaceutical preparations industry.
Sprout Social announces Q3 2026 results and buyback program
Sprout Social reports strong Q3 2026 results, including an 18% revenue growth and a $50 million stock buyback program, signaling confidence in future profitability.
Navitas Semiconductor reports strong Q3 2026 results, growth ahead
Navitas Semiconductor Corp announces significant revenue growth in Q3 2026, driven by high-power markets, and forecasts continued expansion.
Corcept Therapeutics Reports Strong Q3 2026 Financial Results
Corcept Therapeutics announces a 64% revenue increase in Q3 2026, driven by strong sales of its products, including Lifyorli and Korlym.
Contineum Therapeutics announces Q3 2026 financial results
Contineum Therapeutics reports Q3 2026 results, focusing on PIPE-791 for pulmonary fibrosis, with increased R&D expenses and a strong cash position.
BlueLinx Reports Q3 Results with Increased Sales, Net Loss
BlueLinx Holdings Inc. announces third-quarter results showing increased sales but a net loss, indicating ongoing challenges in the wholesale lumber industry.
Marqeta Reports Strong Q3 Results with 29% Volume Growth
Marqeta, Inc. announces third-quarter results, showing 29% growth in processing volume and 7% increase in gross profit, reinforcing its market position.
QuidelOrtho Announces Restructuring Plan and Leadership Changes
QuidelOrtho Corp reveals a new restructuring plan aimed at enhancing efficiency and appoints new leaders for its diagnostics divisions.